HSA-/PLGA-nanoparticles as diagnostic markers for hepatocellular carcinoma (HCC)
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. For curative treatment options, early diagnosis is crucial. In this context, the present invention provides a new contrast agent, made of Gd-DTPA-loaded HSA-/PLGA-nanoparticles for magnetic resonance imaging (MRI) enabling the detection of small HCC which are undetectable with current methods and improving differentiation between HCC and benign lesions in the cirrhotic lever.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Faster, more energy-efficient way to manufacture an industrially important chemical
Zirconium combined with silicon nitride enhances the conversion of propane — present in natural gas — needed to create in-demand plastic, polypropylene. Polypropylene is a common type of plastic found…
Energy planning in Ghana as a role model for the world
Improving the resilience of energy systems in the Global South. What criteria should we use to better plan for resilient energy systems? How do socio-economic, technical and climate change related…
Artificial blood vessels could improve heart bypass outcomes
Artificial blood vessels could improve heart bypass outcomes. 3D-printed blood vessels, which closely mimic the properties of human veins, could transform the treatment of cardiovascular diseases. Strong, flexible, gel-like tubes…
